MICHAEL GRAVES - Corporate Board Profile

EAGLE PHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2015-06-25	Mr. Graves served as the chief executive officer and president of Paddock Laboratories, Inc., a pharmaceutical company, and held various marketing and corporate development roles. He holds a B.S. from State University College of New York at Buffalo.
2016-07-12	Michael Graves has served as a member of our board of directors since November 2013. In June 2016, our board of directors appointed Mr. Graves chairman of the board. In January 2012 Mr. Graves joined the board of directors of RiboCor, Inc. and in December 2011, Mr. Graves was appointed chairman of the board of directors of Nanocopoeia, Inc., both private pharmaceutical companies. From May 2007 to July 2011, Mr. Graves served as the chief executive officer and president of Paddock Laboratories, Inc., a pharmaceutical company engaged in the manufacture, distribution and marketing of bioequivalent generic pharmaceuticals. From September 2005 to November 2006, Mr. Graves served as president of the generic products division at Par Pharmaceutical Companies, Inc., a publicly-traded developer, manufacturer and marketer of specialty pharmaceuticals. While at Par, Mr. Graves oversaw the strategy development of Par's generic pharmaceutical business. Beginning in 1998, Mr. Graves served as director of marketing and sales operations of Par, and in 2004, Mr. Graves was promoted to senior vice president of corporate development and strategic planning. Mr. Graves served in this position until his promotion to president of the generic products division in September 2005. Mr. Graves holds a B.S. from State University College of New York at Buffalo.
2017-04-28	Mr. Graves holds a B.S. from State University College of New York at Buffalo. Our Board believes that Mr. Graves' extensive experience in marketing, sales, business development and operations qualifies him to serve on our Board.
2018-04-30	Mr. Graves' extensive experience in marketing, sales, business development and operations qualifies him to serve on our Board.
2019-04-30	Mr. Graves holds a B.S. from State University College of New York at Buffalo. Our Board believes that Mr. Graves' extensive experience in marketing, sales, business development and operations qualifies him to serve on our Board.
2020-04-29	Mr. Graves served as the chief executive officer and president of Paddock Laboratories, Inc., a pharmaceutical company engaged in the manufacture, distribution and marketing of bioequivalent generic pharmaceuticals... Mr. Graves holds a B.S. from State University College of New York at Buffalo.
2021-04-30	Michael Graves has served as a member of our Board since November 2013... Mr. Graves holds a B.S. from State University College of New York at Buffalo. Our Board believes that Mr. Graves’ extensive experience in marketing, sales, business development and operations qualifies him to serve on our Board.
2022-06-15	Mr. Graves has served as a member of our Board since November 2013... Mr. Graves holds a B.S. from State University College of New York at Buffalo. Our Board believes that Mr. Graves’ extensive experience in marketing, sales, business development and operations qualifies him to serve on our Board.
2023-05-01	Mr. Graves served as the chief executive officer and president of Paddock Laboratories, Inc., a pharmaceutical company... Mr. Graves holds a B.S. from State University College of New York at Buffalo.

Data sourced from SEC filings. Last updated: 2025-07-16